Clinical Trials Browser

Phase 2 × Non-small Cell Lung Cancer With STK11/LKB1 Mutation × Clear all

NCT05807048 2026-03-10

Daratumumab in STK11 Mutated NSCLC

Phase 2 Completed

Non-small Cell Lung Cancer With STK11/LKB1 Mutation